TY - JOUR
T1 - Correction to
T2 - Integrated Safety Analysis of Abrocitinib for the Treatment of Moderate-to-Severe Atopic Dermatitis From the Phase II and Phase III Clinical Trial Program (American Journal of Clinical Dermatology, (2021), 22, 5, (693-707), 10.1007/s40257-021-00618-3)
AU - Simpson, Eric L.
AU - Silverberg, Jonathan I.
AU - Nosbaum, Audrey
AU - Winthrop, Kevin L.
AU - Guttman-Yassky, Emma
AU - Hoffmeister, Karin M.
AU - Egeberg, Alexander
AU - Valdez, Hernan
AU - Zhang, Min
AU - Farooqui, Saleem A.
AU - Romero, William
AU - Thorpe, Andrew J.
AU - Rojo, Ricardo
AU - Johnson, Susan
N1 - Publisher Copyright:
© Springer Nature Switzerland AG 2021.
PY - 2021/11
Y1 - 2021/11
N2 - SpringerLink on 18 August 2021. After publication in volume 22, issue 5, pages 693–707, the authors highlighted that, in Supplemental Table 1, the overall patient numbers for the JADE MONO-2 and JADE COMPARE studies were incorrect. These errors have been rectified and a new corrected version of Supplementary file 1 has been uploaded with the manuscript on SpringerLink. The original article has been corrected.
AB - SpringerLink on 18 August 2021. After publication in volume 22, issue 5, pages 693–707, the authors highlighted that, in Supplemental Table 1, the overall patient numbers for the JADE MONO-2 and JADE COMPARE studies were incorrect. These errors have been rectified and a new corrected version of Supplementary file 1 has been uploaded with the manuscript on SpringerLink. The original article has been corrected.
UR - http://www.scopus.com/inward/record.url?scp=85116931923&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85116931923&partnerID=8YFLogxK
U2 - 10.1007/s40257-021-00638-z
DO - 10.1007/s40257-021-00638-z
M3 - Comment/debate
C2 - 34642878
AN - SCOPUS:85116931923
SN - 1175-0561
VL - 22
SP - 905
JO - American Journal of Clinical Dermatology
JF - American Journal of Clinical Dermatology
IS - 6
ER -